Braze price target raised to $51 from $44 at UBS

UBS raised the firm’s price target on Braze to $51 from $44 and keeps a Neutral rating on the shares. Braze reported a solid 5% organic revenue beat for Q3 and q/q organic days adjusted revs growth accelerated, which was attributed to more even linearity and ACV outperformance, the analyst tells investors in a research note. The slightly softer guide is likely due to conservatism, the firm says.